Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.
about
Apolipoprotein A-IV inhibits experimental colitisLow HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II studyProtective Effects of HDL Against Ischemia/Reperfusion InjuryCardioprotective functions of HDLsThe role of metabolic syndrome in heart failureGPR109A and vascular inflammationHDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 productionLow HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults.Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effectsHigh-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice.Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis.ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects.Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.The role of cholesterol and statins in Alzheimer's disease.Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease.High-density lipoproteins: multifunctional vanguards of the cardiovascular system.Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.Therapeutic approaches to raising plasma HDL-cholesterol levels.Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.Cellular cholesterol homeostasis in vascular endothelial cells.Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.The rationale for using apoA-I as a clinical marker of cardiovascular risk.Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.Effect of plasma lipids and APOE genotype on cognitive decline.Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?HDL and endothelial protection.New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study.HDL therapy for cardiovascular diseases: the road to HDL mimetics.Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammationBIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE.The influence of ApoE genotype on the lipid profile and lipoproteins during normal pregnancy in a Southern African population.Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).Recombinant high-density lipoprotein formulations.
P2860
Q24299366-80148C30-4F83-40F2-A50F-FCD1D757565EQ24642517-0934FF92-D164-435E-BD58-87702B837147Q26772786-A9CECC9E-C198-4284-9961-04D96E2EF61FQ27000421-5C3048E5-78E6-47FC-8C33-2AB9257327DCQ28085668-116E4D46-A4FA-4633-BC2C-77AB1BC4DF00Q28287747-FAA91035-FBFA-4D75-A4D9-C2D5421D3136Q28580308-BE32FB9F-7D92-4B87-8800-CF603DE81FF6Q34038935-8D86E945-2410-4087-B5C1-2F8920E44905Q34095633-E6194046-9BDA-4827-9A6E-60559DEBFC48Q34157008-D69DE6A2-CCC0-49C0-BAF5-F626B0838339Q34287806-4EDC5EEE-CD3A-43DD-B98B-6BAF25863130Q34497101-5572DCAE-326A-488B-8ECF-733E180FA5F5Q34572620-6138845D-BD05-47F9-B6FA-FEEE30FF27C7Q34730815-00438DEB-08F2-4210-A369-C6B745EA43D1Q34743688-3BA37A2C-A48B-4088-BF74-7062BE656741Q35070590-98EA65C9-0415-4BDF-8F4D-A168887AB1EFQ35231847-BB7132AE-767E-4E97-8F3B-8DDAB73048DBQ35638053-3C769550-0E84-4E71-91E2-0F3390E4107EQ35726892-47E190A0-EE0F-419C-87E8-6338D0CF3850Q35777408-0A66C1BE-CDB3-488E-B0DB-E210E991050CQ35815450-54631B89-D49F-44A1-9ED7-4C831668F58AQ35860029-E0C5B56B-F9B2-41FF-956E-D33E59F29997Q36304186-21C70B16-5B59-479F-A0B3-59D8C7BCAC82Q36401585-CA7643DC-1504-43E3-8F75-CF1CEF3FB0D8Q36405130-45FBD15B-21CD-4902-AA22-B6AFAFBF3E62Q36419283-26CF394B-6792-4DF9-88D3-02EF1A4B4132Q36455889-D6008E28-5447-4266-BDDD-1E7F27CE6FB5Q36693904-89E8AA1F-4DF2-4128-A5F0-9BF11D545700Q36755154-FE4540D9-2092-45C0-A3EE-F3FD809FE4E4Q36767859-0B67198F-508E-4807-A214-38637BF06B57Q36929420-9BE929C3-0C1A-48FC-A6C2-A8A94E8FC66EQ37000084-A58C694D-95CA-41CF-8429-63980833C251Q37233240-EB552168-9494-4664-9A89-50E1C438D9CDQ37244748-9D9D3A66-AA6D-41C8-9090-5DCF511105CBQ37257483-307A11C7-96E9-4E26-9BBF-373F10F950E6Q37418039-D12AADBE-EB4A-45F2-9B55-92B8ABD324BCQ37418412-715BBA97-8880-4E29-80D6-5314DEBC5C33Q37431348-FC40E7D6-2A97-41AF-A2A0-809C529BF44DQ37677573-B0DF1955-C340-4F6E-9410-E2E632D77A8DQ37807911-4C7C0A58-1939-49CA-98AA-121F13303D9D
P2860
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Elevation of plasma high-densi ...... o model of acute inflammation.
@en
Elevation of plasma high-densi ...... o model of acute inflammation.
@nl
type
label
Elevation of plasma high-densi ...... o model of acute inflammation.
@en
Elevation of plasma high-densi ...... o model of acute inflammation.
@nl
prefLabel
Elevation of plasma high-densi ...... o model of acute inflammation.
@en
Elevation of plasma high-densi ...... o model of acute inflammation.
@nl
P2093
P921
P356
P1433
P1476
Elevation of plasma high-densi ...... o model of acute inflammation.
@en
P2093
Cockerill GW
Haskard DO
Weerasinghe A
P304
P356
10.1161/01.CIR.103.1.108
P407
P577
2001-01-01T00:00:00Z